FDA approves 1st test for opioid disorder screening
The Food and Drug Administration has approved a tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
The Food and Drug Administration has approved a tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
